Sinopharm Group (SHTDY) Stock Price, News & Analysis

Company Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Key Stats

• Today's Range: $11.57 to $11.98
• 50-Day Range: $10.84 to $12.92
• 52-Week Range: $10.13 to $16.31
• Volume: 6,100 shs
• Average Volume: 18,038 shs
• Market Capitalization: N/A
• P/E Ratio: 2.32
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SHTDY Stock Analysis - Frequently Asked Questions

How have SHTDY shares performed this year?

Sinopharm Group's stock was trading at $13.57 at the beginning of 2025. Since then, SHTDY stock has decreased by 14.7% and is now trading at $11.5705.
View the best growth stocks for 2025 here.

How do I buy shares of Sinopharm Group?

Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:SHTDY
• CIK: 1556605
• Web: www.sinopharmgroup.com.cn
• Phone: 86-21-2305-2666
• Fax: N/A
• Employees: 115,959
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 2.32
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A